BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28871125)

  • 1. HIV-1 matrix protein p17 misfolding forms toxic amyloidogenic assemblies that induce neurocognitive disorders.
    Zeinolabediny Y; Caccuri F; Colombo L; Morelli F; Romeo M; Rossi A; Schiarea S; Ciaramelli C; Airoldi C; Weston R; Donghui L; Krupinski J; Corpas R; García-Lara E; Sarroca S; Sanfeliu C; Slevin M; Caruso A; Salmona M; Diomede L
    Sci Rep; 2017 Sep; 7(1):10313. PubMed ID: 28871125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HIV-1 Matrix Protein p17 Does Cross the Blood-Brain Barrier.
    Caccuri F; Neves V; Gano L; Correia JDG; Oliveira MC; Mazzuca P; Caruso A; Castanho M
    J Virol; 2022 Jan; 96(1):e0120021. PubMed ID: 34668776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications.
    Bugatti A; Paiardi G; Urbinati C; Chiodelli P; Orro A; Uggeri M; Milanesi L; Caruso A; Caccuri F; D'Ursi P; Rusnati M
    Sci Rep; 2019 Oct; 9(1):15768. PubMed ID: 31673058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Autophagy in HIV-1 Matrix Protein p17-Driven Lymphangiogenesis.
    Mazzuca P; Marsico S; Schulze K; Mitola S; Pils MC; Giagulli C; Guzman CA; Caruso A; Caccuri F
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 matrix protein p17: a candidate antigen for therapeutic vaccines against AIDS.
    Fiorentini S; Giagulli C; Caccuri F; Magiera AK; Caruso A
    Pharmacol Ther; 2010 Dec; 128(3):433-44. PubMed ID: 20816696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4(+) T cells.
    Poiesi C; De Francesco MA; Baronio M; Manca N
    Virus Res; 2008 Mar; 132(1-2):25-32. PubMed ID: 18036696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17.
    Giagulli C; D'Ursi P; He W; Zorzan S; Caccuri F; Varney K; Orro A; Marsico S; Otjacques B; Laudanna C; Milanesi L; Dolcetti R; Fiorentini S; Lu W; Caruso A
    Sci Rep; 2017 Jul; 7(1):6555. PubMed ID: 28747658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenic, lymphangiogenic and adipogenic effects of HIV-1 matrix protein p17.
    Basta D; Latinovic O; Lafferty MK; Sun L; Bryant J; Lu W; Caccuri F; Caruso A; Gallo R; Garzino-Demo A
    Pathog Dis; 2015 Nov; 73(8):ftv062. PubMed ID: 26333571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants.
    Lee VS; Tue-ngeun P; Nangola S; Kitidee K; Jitonnom J; Nimmanpipug P; Jiranusornkul S; Tayapiwatana C
    Mol Immunol; 2010 Feb; 47(5):982-90. PubMed ID: 20022377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells.
    Giagulli C; Marsico S; Magiera AK; Bruno R; Caccuri F; Barone I; Fiorentini S; Andò S; Caruso A
    PLoS One; 2011 Mar; 6(3):e17831. PubMed ID: 21423810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
    Caccuri F; D'Ursi P; Uggeri M; Bugatti A; Mazzuca P; Zani A; Filippini F; Salmona M; Ribatti D; Slevin M; Orro A; Lu W; Liò P; Gallo RC; Caruso A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.
    Caccuri F; Giagulli C; Bugatti A; Benetti A; Alessandri G; Ribatti D; Marsico S; Apostoli P; Slevin MA; Rusnati M; Guzman CA; Fiorentini S; Caruso A
    Proc Natl Acad Sci U S A; 2012 Sep; 109(36):14580-5. PubMed ID: 22904195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma.
    Selleri M; Dolcetti R; Caccuri F; Giombini E; Rozera G; Abbate I; Mammone A; Zanussi S; Martorelli D; Fiorentini S; Caruso A; Capobianchi MR
    New Microbiol; 2017 Jan; 40(1):58-61. PubMed ID: 28072889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
    He W; Mazzuca P; Yuan W; Varney K; Bugatti A; Cagnotto A; Giagulli C; Rusnati M; Marsico S; Diomede L; Salmona M; Caruso A; Lu W; Caccuri F
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):13-24. PubMed ID: 30248376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 Matrix Protein p17 and its Receptors.
    Caccuri F; Marsico S; Fiorentini S; Caruso A; Giagulli C
    Curr Drug Targets; 2016; 17(1):23-32. PubMed ID: 26302809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17.
    Fiorentini S; Marsico S; Becker PD; Iaria ML; Bruno R; Guzmán CA; Caruso A
    Vaccine; 2008 Aug; 26(36):4758-65. PubMed ID: 18602957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity.
    Giagulli C; Caccuri F; Cignarella F; Lougaris V; Martorelli D; Bugatti A; Rusnati M; Dolcetti R; Vitali M; Plebani A; Fiorentini S; Caruso A
    AIDS; 2014 Oct; 28(16):2355-64. PubMed ID: 25121556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.
    Giagulli C; Magiera AK; Bugatti A; Caccuri F; Marsico S; Rusnati M; Vermi W; Fiorentini S; Caruso A
    Blood; 2012 Mar; 119(10):2274-83. PubMed ID: 22262769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.